Your browser doesn't support javascript.
loading
Rapid Emergence and Evolution of SARS-CoV-2 Variants in Advanced HIV Infection.
Ko, Sung Hee; Radecki, Pierce; Belinky, Frida; Bhiman, Jinal N; Meiring, Susan; Kleynhans, Jackie; Amoako, Daniel; Guerra Canedo, Vanessa; Lucas, Margaret; Kekana, Dikeledi; Martinson, Neil; Lebina, Limakatso; Everatt, Josie; Tempia, Stefano; Bylund, Tatsiana; Rawi, Reda; Kwong, Peter D; Wolter, Nicole; von Gottberg, Anne; Cohen, Cheryl; Boritz, Eli A.
Afiliación
  • Ko SH; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Radecki P; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Belinky F; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Bhiman JN; National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
  • Meiring S; SAMRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Kleynhans J; National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
  • Amoako D; National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
  • Guerra Canedo V; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Lucas M; National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
  • Kekana D; Department of Integrative Biology and Bioinformatics, College of Biological Sciences, University of Guelph, Ontario, Canada.
  • Martinson N; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Lebina L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Everatt J; National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
  • Tempia S; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Bylund T; Johns Hopkins University, Center for TB Research, Baltimore, MD 21218, USA.
  • Rawi R; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Kwong PD; National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
  • Wolter N; National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
  • von Gottberg A; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Cohen C; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Boritz EA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
bioRxiv ; 2024 Jan 06.
Article en En | MEDLINE | ID: mdl-38313289
ABSTRACT
Previous studies have linked the evolution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic variants to persistent infections in people with immunocompromising conditions1-4, but the evolutionary processes underlying these observations are incompletely understood. Here we used high-throughput, single-genome amplification and sequencing (HT-SGS) to obtain up to ~103 SARS-CoV-2 spike gene sequences in each of 184 respiratory samples from 22 people with HIV (PWH) and 25 people without HIV (PWOH). Twelve of 22 PWH had advanced HIV infection, defined by peripheral blood CD4 T cell counts (i.e., CD4 counts) <200 cells/µL. In PWOH and PWH with CD4 counts ≥200 cells/µL, most single-genome spike sequences in each person matched one haplotype that predominated throughout the infection. By contrast, people with advanced HIV showed elevated intra-host spike diversity with a median of 46 haplotypes per person (IQR 14-114). Higher intra-host spike diversity immediately after COVID-19 symptom onset predicted longer SARS-CoV-2 RNA shedding among PWH, and intra-host spike diversity at this timepoint was significantly higher in people with advanced HIV than in PWOH. Composition of spike sequence populations in people with advanced HIV fluctuated rapidly over time, with founder sequences often replaced by groups of new haplotypes. These population-level changes were associated with a high total burden of intra-host mutations and positive selection at functionally important residues. In several cases, delayed emergence of detectable serum binding to spike was associated with positive selection for presumptive antibody-escape mutations. Taken together, our findings show remarkable intra-host genetic diversity of SARS-CoV-2 in advanced HIV infection and suggest that adaptive intra-host SARS-CoV-2 evolution in this setting may contribute to the emergence of new variants of concern (VOCs).

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos